Exel Composites has signed a frame agreement with Tratos for the supply of composite conductor cores for the period 2026-2029. The agreement includes a minimum volume commitment of at least €22 ...

Have you evaluated the performance of Exelixis' (EXEL) international operations for the quarter ending December 2025? Given the extensive global presence of this drug developer, analyzing the patterns ...

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. If you are wondering whether Exelixis is still reasonably priced after its run, this ...

As a physician, I hear daily from patients across Oregon who struggle to access lifesaving addiction care. The Oregon Senate Committee on Early Childhood and Behavioral Health recently held a public ...

Indiana's syringe exchange law may survive another day ― or more specifically, another five years. Senate Bill 91 passed the House by a 70-22 vote on Feb. 18, after encountering resistance in the ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...

About Exel Industries S.A. EXEL Industries SA engages in the design, manufacture, and marketing of capital goods and associated services in the areas of agricultural equipment, industry, and leisure.

Exelixis, Inc. operates as an oncology company, which focuses on discovering, developing, and commercialization of new medicines for difficult-to-treat cancers. Its products include cabometyx, ...